Posted on 10月 5, 202110/5/21
WEBINAR: The New Path to European Pharmaceutical Commercialisation
Posted on 9月 30, 20219/30/21
EPP Studio Live Webinar — Looking Ahead: Landscape of the Key Price and Market Access Trends in Europe
Posted on 9月 22, 20219/22/21
Getting Treatments to Patients When They Need Them Most: Next Gen Commercialization in Oncology
Posted on 9月 20, 20219/20/21
How Do You Know Your Portfolio Process Is Adding Value?
Posted on 9月 14, 20219/14/21
Simplifying EU Distribution to Maximize Cost Efficiency and Speed to Market for Patients and Manufacturers
Posted on 7月 26, 20217/26/21
Breaking through Barriers: Critical Success Factors for Launching Products with Breakthrough Therapy Designation
Posted on 7月 13, 20217/13/21
Case Study: Launching a New Therapy for HER2-Positive Metastatic Breast Cancer
Posted on 6月 15, 20216/15/21
PharmaVOICE Webinar: Next Gen Commercialization Model for Oncology
Posted on 6月 15, 20216/15/21
Ask the Expert: One-on-One with Amy Hutnik
Posted on 6月 15, 20216/15/21